Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression

NCT03993457 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

18

Enrollment

OTHER

Sponsor class

Stopped terminated during COVID due to inability to see participants in person.

Conditions

Depression

Interventions

DRUG: Escitalopram
DRUG: Bupropion

Sponsor

University of Texas Southwestern Medical Center